Business
Why has the Kazia Therapeutics (ASX:KZA) share price skyrocketed 80% in 1 month?
The Kazia Therapeutics Ltd (ASX: KZA) share price is one of the best performers on the ASX this past month, almost doubling in value before retreating today by 12% to $1.53. Overall, the drugmaker’s share price has gained over 82% during the past month of trading.
Why the big rise in the Kazia share price
Kazia is a Sydney-based, oncology-focused biotechnology drugmaker. The company’s flagship is the paxalisib drug used for the treatment of glioblastoma, which is the most common and aggressive form of primary brain cancer. The Kazia share price has risen strongly on the back of the ongoing and promising development of this particular drug.
In August, paxalisib was granted a fast track designation (FTD) by the United…
-
Noosa News17 hours agoA World-Premiere Exhibition Dedicated to Crocodiles Is Snapping Its Way Into Queensland Museum Kurilpa, Then Touring Nationally
-
General24 hours agoTabcorp fined $4 million for spamming customers with thousands of unlawful marketing messages
-
General17 hours agoGippsland exhibition explores Joseph Turner’s impact on Australian landscape art
-
General23 hours agoWhatsApp to start showing ads to its users